India’s jet fuel demand set to be hit by sharp surge in COVID-19 infections
India’s jet fuel demand is expected to succumb to the latest headwinds the mutant COVID-19 variant as many states in the country impose lockdowns and countries worldwide ban flights, or restrict movements, to and from the South Asian nation to curb the spread of the variant.
“ICRA [Investment Information and Credit Rating Agency] continues to maintain a negative credit outlook on the Indian aviation industry. The outlook reflects ICRA’s view that the financial performance of Indian airlines is likely to remain weak in the near-to-medium term amid weak air traffic,” the agency said recently.
India to take back illegal migrants in return for more UK visas
Boris Johnson and Indian Prime Minister Narendra Modi. (Photo by Stefan Rousseau - Pool/Getty Images)
The UK and India today reached an agreement on migration and mobility between the two countries as they looked to deepen economic ties following Brexit.
The pact will provide more employment opportunities for 3,000 young Indian professionals annually, in return for the country agreeing to take back its citizens who are living illegally in the UK.
“It is our solemn duty that Indian nationals who are undocumented or are in distress abroad and not being given nationality or residence permits, have to be taken back,” Indian foreign ministry official Sandeep Chakravorty told a news conference.
Indiaâs Serum Institute âto invest in UKâ
333
LONDON, May 4, 2021 (BSS/AFP) â Vaccine maker the Serum Institute of India is set to invest in facilities in Britain and could even manufacture inoculations in the UK in future, Prime Minister Boris Johnson said Monday.
Johnsonâs Downing Street office said the $334 million project would include a sales office, âclinical trials, research and development and possibly manufacturing of vaccinesâ.
The Serum Institute of India (SII) is the worldâs largest vaccine maker by volume, and has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot.
SII has also begun phase one trials in the UK of a one-dose nasal vaccine for coronavirus.